STOCK TITAN

[Form 4] Codexis, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Codexis, Inc. (CDXS) Form 4: 10% owner Opaleye Management Inc. reported an open-market purchase of 100,000 common shares on 07/18/2025 at $2.82 per share (≈ $282k). After the transaction, Opaleye now indirectly controls 12,450,000 shares through Opaleye L.P. and 250,000 shares through a separately managed account, totaling ≈ 12.7 million shares. No derivative positions were disclosed. Opaleye disclaims beneficial ownership beyond its pecuniary interest. As a Schedule 13D filer and 10% holder, continued accumulation can signal confidence and tighten the public float, although the added position represents <1 % of its existing stake.

Codexis, Inc. (CDXS) Modulo 4: Il detentore del 10% Opaleye Management Inc. ha dichiarato un acquisto sul mercato aperto di 100.000 azioni ordinarie il 18/07/2025 a 2,82 $ per azione (circa 282.000 $). Dopo l'operazione, Opaleye controlla indirettamente 12.450.000 azioni tramite Opaleye L.P. e 250.000 azioni tramite un conto gestito separatamente, per un totale di circa 12,7 milioni di azioni. Non sono state dichiarate posizioni in derivati. Opaleye nega la proprietà beneficiaria oltre al suo interesse pecuniario. In quanto presentatore del Schedule 13D e detentore del 10%, un accumulo continuativo può indicare fiducia e ridurre il flottante pubblico, anche se la posizione aggiuntiva rappresenta meno dell'1% della sua partecipazione attuale.

Codexis, Inc. (CDXS) Formulario 4: El propietario del 10% Opaleye Management Inc. reportó una compra en mercado abierto de 100,000 acciones comunes el 18/07/2025 a $2.82 por acción (aproximadamente $282,000). Tras la transacción, Opaleye controla indirectamente 12,450,000 acciones a través de Opaleye L.P. y 250,000 acciones mediante una cuenta gestionada por separado, sumando un total de aproximadamente 12.7 millones de acciones. No se divulgaron posiciones en derivados. Opaleye niega la propiedad beneficiaria más allá de su interés pecuniario. Como presentador del Schedule 13D y titular del 10%, la acumulación continua puede indicar confianza y reducir el flotante público, aunque la posición añadida representa menos del 1% de su participación actual.

Codexis, Inc. (CDXS) 양식 4: 10% 지분 보유자인 Opaleye Management Inc.가 2025년 7월 18일에 주당 $2.82에 100,000주를 시장 내 매수했다고 보고했습니다(약 282,000달러). 거래 후 Opaleye는 Opaleye L.P.를 통해 간접적으로 12,450,000주를, 별도 관리 계정을 통해 250,000주를 보유하여 총 약 1,270만 주를 통제하고 있습니다. 파생상품 포지션은 공개되지 않았습니다. Opaleye는 경제적 이익을 넘는 실질 소유권을 부인합니다. Schedule 13D 제출자이자 10% 보유자로서 지속적인 매수는 신뢰를 나타내고 유동 주식 수를 줄일 수 있으나, 추가 매수분은 기존 지분의 1% 미만에 해당합니다.

Codexis, Inc. (CDXS) Formulaire 4 : Le détenteur de 10% Opaleye Management Inc. a déclaré un achat sur le marché ouvert de 100 000 actions ordinaires le 18/07/2025 à 2,82 $ par action (environ 282 000 $). Après la transaction, Opaleye contrôle indirectement 12 450 000 actions via Opaleye L.P. et 250 000 actions via un compte géré séparément, totalisant environ 12,7 millions d’actions. Aucune position dérivée n’a été divulguée. Opaleye décline toute propriété bénéficiaire au-delà de son intérêt pécuniaire. En tant que déposant du Schedule 13D et détenteur de 10%, une accumulation continue peut signaler la confiance et réduire le flottant public, bien que la position ajoutée représente moins de 1% de sa participation actuelle.

Codexis, Inc. (CDXS) Formular 4: Der 10%-Eigentümer Opaleye Management Inc. meldete am 18.07.2025 einen Kauf am offenen Markt von 100.000 Stammaktien zu je 2,82 $ (ca. 282.000 $). Nach der Transaktion kontrolliert Opaleye nun indirekt 12.450.000 Aktien über Opaleye L.P. und 250.000 Aktien über ein separat verwaltetes Konto, insgesamt etwa 12,7 Millionen Aktien. Es wurden keine Derivatpositionen offengelegt. Opaleye weist eine wirtschaftliche Eigentümerschaft über sein finanzielles Interesse hinaus zurück. Als Schedule 13D-Melder und 10%-Inhaber kann eine fortgesetzte Akkumulation Vertrauen signalisieren und die Streuung verringern, obwohl die hinzugefügte Position weniger als 1% seines bestehenden Anteils ausmacht.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: 10% owner bought 100k CDXS shares at $2.82, nudging stake to 12.7 M; small addition but positive insider signal.

Opaleye’s purchase increases its indirect ownership by roughly 0.8 %, bringing its total to about 12.7 million shares. While the dollar value is modest relative to its holding, insider buying—especially by a large shareholder—tends to be interpreted favorably because the investor is committing fresh capital at prevailing market prices. No dispositions or derivative exercises were reported, indicating a straightforward cash purchase. The filing is impactful mainly as a sentiment indicator; it does not alter Codexis’s fundamentals or capital structure but may support near-term share demand and investor confidence.

Codexis, Inc. (CDXS) Modulo 4: Il detentore del 10% Opaleye Management Inc. ha dichiarato un acquisto sul mercato aperto di 100.000 azioni ordinarie il 18/07/2025 a 2,82 $ per azione (circa 282.000 $). Dopo l'operazione, Opaleye controlla indirettamente 12.450.000 azioni tramite Opaleye L.P. e 250.000 azioni tramite un conto gestito separatamente, per un totale di circa 12,7 milioni di azioni. Non sono state dichiarate posizioni in derivati. Opaleye nega la proprietà beneficiaria oltre al suo interesse pecuniario. In quanto presentatore del Schedule 13D e detentore del 10%, un accumulo continuativo può indicare fiducia e ridurre il flottante pubblico, anche se la posizione aggiuntiva rappresenta meno dell'1% della sua partecipazione attuale.

Codexis, Inc. (CDXS) Formulario 4: El propietario del 10% Opaleye Management Inc. reportó una compra en mercado abierto de 100,000 acciones comunes el 18/07/2025 a $2.82 por acción (aproximadamente $282,000). Tras la transacción, Opaleye controla indirectamente 12,450,000 acciones a través de Opaleye L.P. y 250,000 acciones mediante una cuenta gestionada por separado, sumando un total de aproximadamente 12.7 millones de acciones. No se divulgaron posiciones en derivados. Opaleye niega la propiedad beneficiaria más allá de su interés pecuniario. Como presentador del Schedule 13D y titular del 10%, la acumulación continua puede indicar confianza y reducir el flotante público, aunque la posición añadida representa menos del 1% de su participación actual.

Codexis, Inc. (CDXS) 양식 4: 10% 지분 보유자인 Opaleye Management Inc.가 2025년 7월 18일에 주당 $2.82에 100,000주를 시장 내 매수했다고 보고했습니다(약 282,000달러). 거래 후 Opaleye는 Opaleye L.P.를 통해 간접적으로 12,450,000주를, 별도 관리 계정을 통해 250,000주를 보유하여 총 약 1,270만 주를 통제하고 있습니다. 파생상품 포지션은 공개되지 않았습니다. Opaleye는 경제적 이익을 넘는 실질 소유권을 부인합니다. Schedule 13D 제출자이자 10% 보유자로서 지속적인 매수는 신뢰를 나타내고 유동 주식 수를 줄일 수 있으나, 추가 매수분은 기존 지분의 1% 미만에 해당합니다.

Codexis, Inc. (CDXS) Formulaire 4 : Le détenteur de 10% Opaleye Management Inc. a déclaré un achat sur le marché ouvert de 100 000 actions ordinaires le 18/07/2025 à 2,82 $ par action (environ 282 000 $). Après la transaction, Opaleye contrôle indirectement 12 450 000 actions via Opaleye L.P. et 250 000 actions via un compte géré séparément, totalisant environ 12,7 millions d’actions. Aucune position dérivée n’a été divulguée. Opaleye décline toute propriété bénéficiaire au-delà de son intérêt pécuniaire. En tant que déposant du Schedule 13D et détenteur de 10%, une accumulation continue peut signaler la confiance et réduire le flottant public, bien que la position ajoutée représente moins de 1% de sa participation actuelle.

Codexis, Inc. (CDXS) Formular 4: Der 10%-Eigentümer Opaleye Management Inc. meldete am 18.07.2025 einen Kauf am offenen Markt von 100.000 Stammaktien zu je 2,82 $ (ca. 282.000 $). Nach der Transaktion kontrolliert Opaleye nun indirekt 12.450.000 Aktien über Opaleye L.P. und 250.000 Aktien über ein separat verwaltetes Konto, insgesamt etwa 12,7 Millionen Aktien. Es wurden keine Derivatpositionen offengelegt. Opaleye weist eine wirtschaftliche Eigentümerschaft über sein finanzielles Interesse hinaus zurück. Als Schedule 13D-Melder und 10%-Inhaber kann eine fortgesetzte Akkumulation Vertrauen signalisieren und die Streuung verringern, obwohl die hinzugefügte Position weniger als 1% seines bestehenden Anteils ausmacht.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Opaleye Management Inc.

(Last) (First) (Middle)
ONE BOSTON PLACE,
26TH FLOOR

(Street)
BOSTON MA 02108

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CODEXIS, INC. [ CDXS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.001 per share 07/18/2025 P 100,000 A $2.82 12,450,000 I By Opaleye, L.P.(1)(3)
Common Stock, par value $0.001 per share 250,000 I By Managed Account(2)(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
2. Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
3. Opaleye Management Inc. disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Opaleye Management Inc. is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Opaleye Management Inc., By: /s/ James Silverman, President 07/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Codexis Inc

NASDAQ:CDXS

CDXS Rankings

CDXS Latest News

CDXS Latest SEC Filings

CDXS Stock Data

232.79M
80.50M
2.44%
80.52%
3.66%
Biotechnology
Industrial Organic Chemicals
Link
United States
REDWOOD CITY